HCP (NYSE:HCP) had its price target dropped by Robert W. Baird from $29.00 to $26.00 in a report issued on Friday, MarketBeat reports. The firm currently has a “neutral” rating on the real estate investment trust’s stock. Robert W. Baird’s target price suggests a potential upside of 3.96% from the stock’s current price.

A number of other brokerages also recently weighed in on HCP. KeyCorp reissued a “hold” rating on shares of HCP in a report on Sunday, September 17th. Bank of America downgraded shares of HCP from a “buy” rating to a “neutral” rating and cut their price target for the company from $33.00 to $31.00 in a report on Friday, September 22nd. Morgan Stanley cut their price target on shares of HCP from $31.00 to $29.00 and set an “equal weight” rating for the company in a report on Monday, September 25th. UBS Group downgraded shares of HCP from a “neutral” rating to a “sell” rating and cut their price target for the company from $30.00 to $25.00 in a report on Monday, October 2nd. Finally, Stifel Nicolaus reissued a “hold” rating and issued a $30.00 price target on shares of HCP in a report on Wednesday, October 4th. Four equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $30.36.

Shares of HCP (HCP) opened at $25.01 on Friday. HCP has a 1-year low of $24.75 and a 1-year high of $33.67. The company has a debt-to-equity ratio of 1.17, a current ratio of 0.61 and a quick ratio of 0.61. The firm has a market cap of $11,730.00, a PE ratio of 44.66, a price-to-earnings-growth ratio of 2.80 and a beta of 0.33.

HCP (NYSE:HCP) last issued its quarterly earnings results on Thursday, November 2nd. The real estate investment trust reported $0.48 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.46 by $0.02. HCP had a net margin of 27.31% and a return on equity of 8.85%. The company had revenue of $454.00 million during the quarter, compared to the consensus estimate of $440.60 million. During the same period in the prior year, the company earned $0.72 EPS. HCP’s revenue was down 14.4% on a year-over-year basis. equities research analysts anticipate that HCP will post 1.94 earnings per share for the current fiscal year.

A number of hedge funds have recently bought and sold shares of HCP. Sun Life Financial INC lifted its stake in HCP by 42,675.0% during the second quarter. Sun Life Financial INC now owns 3,422 shares of the real estate investment trust’s stock valued at $109,000 after buying an additional 3,414 shares in the last quarter. Advisory Services Network LLC increased its holdings in shares of HCP by 4.1% in the 2nd quarter. Advisory Services Network LLC now owns 3,782 shares of the real estate investment trust’s stock valued at $121,000 after purchasing an additional 150 shares during the period. Fieldpoint Private Securities LLC acquired a new position in shares of HCP in the 3rd quarter valued at about $147,000. Penserra Capital Management LLC acquired a new position in shares of HCP in the 3rd quarter valued at about $163,000. Finally, Koch Industries Inc. acquired a new position in shares of HCP in the 2nd quarter valued at about $208,000. 89.88% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: “Robert W. Baird Cuts HCP (HCP) Price Target to $26.00” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://www.watchlistnews.com/robert-w-baird-cuts-hcp-hcp-price-target-to-26-00/1797677.html.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with Analyst Ratings Network's FREE daily email newsletter.